Aaron Ondrey reports a stock award at Syndax Pharmaceuticals
By AlphaYouPublished Form 4
Ondrey Aaron
Reporting filer
Aaron Ondrey reports a stock award, not an open-market purchase or sale, in Syndax Pharmaceuticals Inc. Form 4 filed Nov 12, 2026 lists 1 entry.
- Disclosed
- Nov 12, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy) (derivative) | Ondrey Aaron | 2026-11-09 | A | Grant or award | 270000 | 9.55 | 0 | 3 days | Filed terms
|
Stock Option (Right to buy) (derivative)
- Owner
- Ondrey Aaron
- Date
- 2026-11-09
- Code
- A
- Action
- Grant or award
- Quantity
- 270000
- Price
- 9.55
- Following holdings
- 0
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to buy)
- conversion Or Exercise Price: 9.55
- transaction Date: 2026-11-09
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Shares: 270000
- transaction Price Per Share: 9.55
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-11-09
- underlying Security Title: Common Stock
- underlying Security Shares: 270000
- shares Owned Following Transaction: 0
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Ondrey Aaron: Chief Financial Officer.
- F1: Twenty-five percent (25%) of the total number of shares will vest on the one (1) year anniversary of the Vesting Commencement Date and one forty-eighth (1/48th) of the shares of Common Stock subject to the Option shall vest monthly thereafter during the recipient's continued service as an employee, consultant, director or officer of the Company over the following thirty-six (36) months, until all of the shares subject to the Option are fully vested.
Original sources
Prepared automatically from public filing data. Report a correction.